Beau Webber, PhD, University of Minnesota, “Gene-edited tumor infiltrating lymphocytes for ovarian cancer immunotherapy”, University of Minnesota, $100,000 for one year

Xinyan Wu, PhD, Mayo Clinic, “Investigating Soluble AXL as a Biomarker in Ovarian Cancer: Implications for Prognosis and Treatment”, $100,000 for one year

Tim Griffin, PhD, University of Minnesota, “A rigorous validation of a novel host-microbe peptide panel for ovarian cancer early detection from routinely collected samples”, $100,000 for one year

Arun Kanakkanthara, PhD, Mayo Clinic, “A novel therapy for high-grade serous ovarian cancer”, $100,000 for one year

Matthew Block, MD, PhD, Mayo Clinic, “MC220601: FRaDCs plus Pembrolizumab for Patients with Advanced Stage Ovarian Cancer”, $100,000 for one year

MOCA has committed an additional $100,000 to our National Early Detection Research Awards in 2024. Awards will be announced in November.

MOCA’s past research funding awards listing.